Navigation Links
Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012
Date:2/8/2012

idation of our oral peptide drug delivery technology platform and Biotechnologies strategy.  We will rely on Jane and the rest of the team to continue the SBU's solid momentum.  I am confident Jane will contribute significantly to the continued effective turnaround and overall success of Unigene."

Concurrent with her position in BD&L at Novartis, Dr. Pepper also led development activities for Novartis' Gilenya® (fingolimod), which was first launched in the U.S. in 2010.  Before Novartis, she was a co-founder and senior scientist at SRU Biosystems and prior to that role, a project leader and staff scientist at Draper Laboratory. 

Dr. Pepper holds a Ph.D. in chemistry from Tufts University and an MBA from Rutgers University.  She is the co-inventor and co-author of more than 10 U.S. and worldwide patents and has a book and 10 research articles to her credit.

About Unigene Laboratories, Inc.
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements, including statements relating to whether: Tarsa's efforts to seek FDA approval for OSTORA, including the possible timing of an NDA submission in the second half of 2012; Tarsa's use of the
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
2. Unigene Provides 2012 Business Outlook
3. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
4. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
5. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
6. Unigene Reports Third Quarter 2011 Financial Results
7. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
8. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
9. Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain
10. Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
11. Cardica Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014  IBM (NYSE: IBM ... ( DESY ), a leading national research center in ... and storage of massive volumes of x-ray data. The ... on IBM software defined technology can handle more than ... and help scientists worldwide gain faster insights into the ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans believe ... is a serious public health and safety issue in ... a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse ... with this very serious health situation facing our country," ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... , , , ... the leader in the development of devices for the percutaneous ... group of patients with the MitraClip((R)) system at the Elisabethinen ... device commercially available in the European Union which provides a ...
... HERNDON, Va., Sept. 8 BHR Pharma, ... global, Phase 3, multi-center pivotal trial ( www.synapse-trial.com ) ... product as a neuroprotective agent for treating severe traumatic brain injury ... will enroll approximately 1,200 patients with severe (Glasgow Coma Scale scores ...
Cached Medicine Technology:MitraClip(R) Therapy Introduced in Austria 2MitraClip(R) Therapy Introduced in Austria 3BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 2
(Date:8/21/2014)... -- Not only is eating better and exercising healthy for ... dollars a year, a new study finds. The study, ... at Wake Forest Baptist Medical Center in Winston-Salem, N.C., ... patients. Participants ranged in age from 45 ... "lifestyle change program" focused on diet and exercise, or to ...
(Date:8/21/2014)... Dennis Thompson HealthDay Reporter ... combination of therapy and antidepressants appears to best help ... reports. Four out of five people suffering from ... recovery when treated with cognitive therapy plus antidepressant medication, ... didn,t work much better than drugs alone in helping ...
(Date:8/21/2014)... 2014 A new study published this ... in disability associated with speech problems from 2001-02 to ... 15% increase in disability associated with hearing problems. The ... numbers of children who are experiencing communication disorders, according ... , On a broader level, the new study, ...
(Date:8/21/2014)... Many primary care physicians in rural communities do ... (IPV), according to Penn State medical and public ... such violence have limited resources if they seek ... to help women," said Jennifer S. McCall-Hosenfeld, a ... and public health sciences, Penn State College of ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... blood thinner caused patients to suffer uncontrollable internal bleeding ... courts, Bernstein Liebhard LLP reports. According to court documents, ... in U.S. District Court, Easter District of New York ... due to a bleeding event that was allegedly caused ...
Breaking Medicine News(10 mins):Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 3Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 4
... , , EDEN PRAIRIE, Minn., July 14 ... by Elton John, Billy Crystal, Tony Bennett, and Gladys Knight ... the gift of hearing, raising more than $5 million to ... Hearing Foundation hosted its Ninth Annual "So the World May ...
... change disease from fatal to chronic, researcher says , ... a network of mutated genes and gene processes that, ... type of brain tumor. , "There is not a ... tumors," explained Dr. Markus Bredel, co-author of two related ...
... , , , , ... HLTH ) and its approximately 83% owned subsidiary, WebMD Health Corp. (Nasdaq: ... results for the three months ended June 30, 2009 at approximately 4:00 pm ... at 4:45 pm (ET) on that day to discuss those results. ...
... July 14 Warner Chilcott Limited (Nasdaq: WCRX ) announced ... to the market opening on Friday, August 7, 2009. , ... the Company will host a conference call for all interested parties on ... results. To participate in the call, please dial (888) 208-1812 in the ...
... , CHICAGO, July 14 Earlier today a ... ruling in Zbaraz v. Madigan, a case considering the constitutionality of the ... predecessors -- had long been enjoined from enforcement until today,s ruling. The ... for the ACLU of Illinois : , ...
... ... for surgeon general. , ... Washington, DC (Vocus) June 14, 2009 --    U.S. African Chamber Of Commerce ... physician has been an advocate for universal care, and is expected to have a ...
Cached Medicine News:Health News:Elton John, Billy Crystal, Tony Bennett, and Gladys Knight Help Starkey Hearing Foundation Raise More than $5 Million at Annual Fundraiser 2Health News:Elton John, Billy Crystal, Tony Bennett, and Gladys Knight Help Starkey Hearing Foundation Raise More than $5 Million at Annual Fundraiser 3Health News:Gene Connections Key to Brain Tumor Growth 2Health News:Gene Connections Key to Brain Tumor Growth 3Health News:HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 3
... The Nightingale Monitoring System™ expands hospital-grade monitoring ... of subacute care and disease state management. ... ability to encompass a full range of ... patients inside the hospital, to periodic monitoring ...
... FlexNet adds wireless capability to ... This expands the Flexible Monitoring concept ... patient information from anywhere to anywhere. ... ambulatory wireless monitors and hardwired and ...
... Wireless Propaq CS makes ... the Propaq CS even ... with Symbol Technologies, the ... into wireless ethernet Local ...
... The original Welch Allyn ... excellent choice for clinical areas ... Simple and straightforward to use, ... noninvasive blood pressure, and optional ...
Medicine Products: